Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
| 7.22 Delayed Data As of 3:59pm ET |  -0.01 / -0.14%Today’s Change | 6.78 Today|||52-Week Range 11.45 | -20.83% Year-to-Date |
Latest TEVA News | Press Releases
| Teva Pharmaceuticals Just Made a Big Announcement, but Is It a Buy? 10:00am / MotleyFool.com - Paid Partner Content | 3 Generic Drug Stocks to Watch Amid Macro Headwinds May 23 / Zacks.com - Paid Partner Content |
| Zacks Industry Outlook Highlights Amphastar, Dr. Reddy's and Teva Pharmaceutical May 24 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 7.23 |
| Today’s open | 7.23 |
| Day’s range | 7.14 - 7.24 |
| Volume | 10,116,211 |
| Average volume (3 months) | 10,939,957 |
| Market cap | $8.1B |
Data as of 3:59pm ET, 06/05/2023
Growth & Valuation
| Earnings growth (last year) | -660.20% |
| Earnings growth (this year) | -9.06% |
| Earnings growth (next 5 years) | +1.78% |
| Revenue growth (last year) | -5.89% |
| P/E ratio | NM |
| Price/Sales | 0.68 |
| Price/Book | 1.02 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BBIOBridgeBio Pharma Inc | +0.34 | +2.38% |
| IDRSFIdorsia Ltd | +0.10 | +1.16% |
| ---- | ||
| IMMBImmunotech Laborator... | 0.00 | 0.00% |
Data as of 3:59pm ET, 06/05/2023
Financials
| Next reporting date | August 9, 2023 |
| EPS forecast (this quarter) | $0.53 |
| Annual revenue (last year) | $14.9B |
| Annual profit (last year) | -$2.4B |
| Net profit margin | -15.78% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Generic |
No executives to display |
Corporate headquarters Tel Aviv, Tel Aviv |
Forecasts
